SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ali S. Shalash, Solaf M. Elsayed, Suzan Elnaghi, Susanne A. Schneider, Tawhida Y. Ghaffar, Prominent extensor truncal dystonia in egyptian patients with Wilson's disease, Movement Disorders, 2014, 29, 1
  2. 2
    Maria Stamelou, Scarlett C. Lai, Annu Aggarwal, Susanne A. Schneider, Henry Houlden, Tu-Hsueh Yeh, Amit Batla, Chin-Song Lu, Mohit Bhatt, Kailash P. Bhatia, Dystonic opisthotonus: A “red flag” for neurodegeneration with brain iron accumulation syndromes?, Movement Disorders, 2013, 28, 10
  3. 3
    C. Rech, A. -C. de Crouy, Paralysie cérébrale : organisation de la transition enfant-adulte et spécificités de la prise en charge MPR de l’adulte, La Lettre de médecine physique et de réadaptation, 2013, 29, 1, 25

    CrossRef

  4. 4
    Michele Tinazzi, Ina Juergenson, Giovanna Squintani, Gaetano Vattemi, Stefania Montemezzi, Daniela Censi, Paolo Barone, Tommaso Bovi, Alfonso Fasano, Pisa syndrome in Parkinson’s disease: an electrophysiological and imaging study, Journal of Neurology, 2013, 260, 8, 2138

    CrossRef

  5. 5
    H. A. Jinnah, Alfredo Berardelli, Cynthia Comella, Giovanni DeFazio, Mahlon R. DeLong, Stewart Factor, Wendy R. Galpern, Mark Hallett, Christy L. Ludlow, Joel S. Perlmutter, Ami R. Rosen, The focal dystonias: Current views and challenges for future research, Movement Disorders, 2013, 28, 7
  6. 6
    A. Brotier, C. Rech, J. Levy, L. Mandon, C. Hugeron, D. Ben Smail, Dystonie lombaire en extension avec lyse isthmique : intérêt de la toxine botulique dans les muscles spinaux à visée antalgique. À propos d’un cas et revue de la littérature, Annals of Physical and Rehabilitation Medicine, 2012, 55, e336

    CrossRef

  7. 7
    A. Brotier, C. Rech, J. Levy, L. Mandon, C. Hugeron, D. Ben Smail, Extensor truncal dystonia with spondylolysis: Interest of botulinum toxin in the spinal muscles for pain relief, Annals of Physical and Rehabilitation Medicine, 2012, 55, e339

    CrossRef

  8. 8
    Francisco Cardoso, Handbook of Dystonia, 2012,

    CrossRef

  9. 9
    Alessandro Matteo, Alfonso Fasano, Giovanna Squintani, Lucia Ricciardi, Tommaso Bovi, Antonio Fiaschi, Paolo Barone, Michele Tinazzi, Lateral trunk flexion in Parkinson’s disease: EMG features disclose two different underlying pathophysiological mechanisms, Journal of Neurology, 2011, 258, 5, 740

    CrossRef

  10. 10
    Raymond L. Rosales, Arlene R. Ng, Mary Mildred Delgado-Delos Santos, Hubert H. Fernandez, The Broadening Application of Chemodenervation in X-Linked Dystonia-Parkinsonism (Part II): An Open-Label Experience With Botulinum Toxin-A (Dysport®) Injections for Oromandibular, Lingual, and Truncal-Axial Dystonias, International Journal of Neuroscience, 2011, 121, S1, 44

    CrossRef

  11. 11
    Andrea Santamato, Maurizio Ranieri, Francesco Panza, Stefano Zoccolella, Vincenza Frisardi, Vincenzo Solfrizzi, Maria Teresa Amoruso, Loredana Amoruso, Pietro Fiore, Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson’s disease, Journal of Neurology, 2010, 257, 1, 139

    CrossRef

  12. 12
    Louise C. Jeynes, Charles A. Gauci, Evidence for the Use of Botulinum Toxin in the Chronic Pain Setting—A Review of the Literature, Pain Practice, 2008, 8, 4
  13. 13
    Johannes M.H. Hennings, Eike Krause, Kai Bötzel, Thomas C. Wetter, Successful treatment of tardive lingual dystonia with botulinum toxin: Case report and review of the literature, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008, 32, 5, 1167

    CrossRef

  14. 14
    G. Marrè-Brunenghi, R. Camoriano, M. Valle, S. Boero, The psoas muscle as cause of low back pain in infantile cerebral palsy, Journal of Orthopaedics and Traumatology, 2008, 9, 1, 43

    CrossRef

  15. 15
    Laura Bonanni, Astrid Thomas, Sara Varanese, Vincenzo Scorrano, Marco Onofrj, Botulinum toxin treatment of lateral axial dystonia in parkinsonism, Movement Disorders, 2007, 22, 14
  16. 16
    Daniel D. Truong, Wolfgang H. Jost, Botulinum toxin: Clinical use, Parkinsonism & Related Disorders, 2006, 12, 6, 331

    CrossRef

  17. 17
    Francisco Cardoso, Handbook of Dystonia, 2006,

    CrossRef

  18. 18
    Frank Skidmore, Stephen G. Reich, Tardive dystonia, Current Treatment Options in Neurology, 2005, 7, 3, 231

    CrossRef

  19. 19
    Philippe Gallien, Benoît Nicolas, Sabine Petrilli, Valérie Kerdoncuff, Arnaud Lassalles, Hélène Le Tallec, Aurélie Durufle, Place de la toxine botulique dans les rachialgies de l’IMC adulte. À propos d’une observation, Revue du Rhumatisme, 2004, 71, 1, 85

    CrossRef

  20. 20
    Philippe Gallien, Benoît Nicolas, Sabine Petrilli, Valérie Kerdoncuff, Arnaud Lassalles, Hélène Le Tallec, Aurélie Durufle, Role for botulinum toxin in back pain treatment in adults with cerebral palsy: report of a case, Joint Bone Spine, 2004, 71, 1, 76

    CrossRef

  21. 21
    Allan Herskowitz, Brad Herskowitz, Treatment of Neck and Shoulder Pain with Botulinum Neurotoxins, Pain Practice, 2004, 4,
  22. 22
    Hubert H. Fernandez, Joseph H. Friedman, CLASSIFICATION AND TREATMENT OF TARDIVE SYNDROMES, The Neurologist, 2003, 9, 1, 16

    CrossRef

  23. 23
    A. Albanese, The current status and use of botulinum toxins, European Journal of Neurology, 2001, 8,
  24. 24
    Anna Rita Bentivoglio, Alberto Albanese, Botulinum toxin in motor disorders, Current Opinion in Neurology, 1999, 12, 4, 447

    CrossRef

  25. 25
    Barry M. Guyer, Mechanism of botulinum toxin in the relief of chronic pain, Current Review of Pain, 1999, 3, 6, 427

    CrossRef